The WGNV is an informal network of stakeholders engaged in all aspects of TB vaccine R&D and from all constituencies, including academics, product developers, clinicians, advocates, funders, policymakers, and affected communities. Membership is free and open to anyone who is supportive of the development of improved vaccines to prevent TB.
Members will be kept informed via email of new developments in TB vaccine research and development, new resources, opportunities, and other information related to TB vaccine R&D.
By submitting this form, you consent to the storage and use of your information by IAVI and the Working Group on New TB Vaccines (WGNV), to verify your information and contact you in connection with the WGNV Program. All information will be stored and used in compliance with our Privacy Policy.
We use Mailchimp as our marketing platform. By submitting this form, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.